Sarcoidosis 1. Study: "Cellular Therapy Could Soothe Sarcoidosis"
o Findings: MSCs may modulate immune responses and reduce inflammation in sarcoidosis, offering a potential therapeutic approach.
o Source: NIH Intramural Research Program
Polycystic Ovary Syndrome (PCOS) 1. Study: "MSC therapy for polycystic ovary syndrome: emerging evidence." o Findings: MSCs improve ovarian function, regulate hormones, and reduce inflammation in PCOS patients.
Source: MDPI
o
Epilepsy 1. Study: "The Anti-Inflammatory Properties of Mesenchymal Stem Cells in Epilepsy: Possible Treatments and Future Perspectives.” o Findings: MSCs protect neurons, reduce seizure frequency, and modulate neuroinflammation in epilepsy.
o Source: Journal of Translational Medicine
Hypoxic-Ischemic Encephalopathy (HIE) 1. Study: "MSC therapy for neonatal hypoxic-ischemic encephalopathy: outcomes and mechanisms."
o Findings: MSCs reduce neuronal damage, promote repair, and improve outcomes in HIE.
Source: PubMed
o
Heavy Metals 1. Study: "Challenges of mesenchymal stem cells in the clinical treatment of COVID-19" o Findings: The study discusses MSCs' potential in reducing oxidative stress and promoting tissue repair, which may be applicable to heavy metal toxicity.
o Source: Cell and Tissue Research
© 2024 Longevity Medical Institute. All rights reserved.
21
Made with FlippingBook Annual report maker